135 related articles for article (PubMed ID: 38112953)
1. Aldo-keto reductase 1C2 (AKR1C2) as the second gene associated to non-syndromic primary lipedema: investigating activating mutation or overexpression as causative factors.
Kaftalli J; Donato K; Bonetti G; Dhuli K; Macchia A; Maltese PE; Louise Herbst K; Michelini S; Chiurazzi P; Hill M; Michelini S; Michelini S; Marceddu G; Bernini A; Bertelli M
Eur Rev Med Pharmacol Sci; 2023 Dec; 27(6 Suppl):127-136. PubMed ID: 38112953
[TBL] [Abstract][Full Text] [Related]
2. Author Correction: Aldo-keto reductase 1C2 (AKR1C2) as the second gene associated to non-syndromic primary lipedema: investigating activating mutation or overexpression as causative factors.
Kaftalli J; Donato K; Bonetti G; Dhuli K; Macchia A; Maltese PE; Louise Herbst K; Michelini S; Chiurazzi P; Hill M; Michelini S; Michelini S; Marceddu G; Bernini A; Bertelli M
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2626. PubMed ID: 38567622
[TBL] [Abstract][Full Text] [Related]
3. Aldo-Keto Reductase 1C1 (
Michelini S; Chiurazzi P; Marino V; Dell'Orco D; Manara E; Baglivo M; Fiorentino A; Maltese PE; Pinelli M; Herbst KL; Dautaj A; Bertelli M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872468
[TBL] [Abstract][Full Text] [Related]
4. Function, drug resistance and prognostic effect of AKR1C2 in human cancer.
Wang Z; Feng Y; Song J; Sun D; Zhang YY
Neoplasma; 2023 Jun; 70(3):319-332. PubMed ID: 37498066
[TBL] [Abstract][Full Text] [Related]
5. Human dehydrogenase/reductase SDR family member 11 (DHRS11) and aldo-keto reductase 1C isoforms in comparison: Substrate and reaction specificity in the reduction of 11-keto-C
Endo S; Morikawa Y; Kudo Y; Suenami K; Matsunaga T; Ikari A; Hara A
J Steroid Biochem Mol Biol; 2020 May; 199():105586. PubMed ID: 31926269
[TBL] [Abstract][Full Text] [Related]
6. Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells.
Rizner TL; Lin HK; Peehl DM; Steckelbroeck S; Bauman DR; Penning TM
Endocrinology; 2003 Jul; 144(7):2922-32. PubMed ID: 12810547
[TBL] [Abstract][Full Text] [Related]
7. Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis.
Hevir N; Vouk K; Sinkovec J; Ribič-Pucelj M; Rižner TL
Chem Biol Interact; 2011 May; 191(1-3):217-26. PubMed ID: 21232532
[TBL] [Abstract][Full Text] [Related]
8. AKR1C1 and hormone metabolism in lipedema pathogenesis: a computational biology approach.
Kaftalli J; Bonetti G; Marceddu G; Dhuli K; Maltese PE; Donato K; Herbst KL; Michelini S; Chiurazzi P; Hill M; Michelini S; Michelini S; Bernini A; Bertelli M
Eur Rev Med Pharmacol Sci; 2023 Dec; 27(6 Suppl):137-147. PubMed ID: 38112954
[TBL] [Abstract][Full Text] [Related]
9. Long-chain fatty acids inhibit human members of the aldo-keto reductase 1C subfamily.
Hara A; Endo S; Matsunaga T; Soda M; Yashiro K; El-Kabbani O
J Biochem; 2017 Nov; 162(5):371-379. PubMed ID: 28992312
[TBL] [Abstract][Full Text] [Related]
10. Tibolone metabolism in human liver is catalyzed by 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four isoforms of the aldo-keto reductase (AKR)1C subfamily.
Steckelbroeck S; Oyesanmi B; Jin Y; Lee SH; Kloosterboer HJ; Penning TM
J Pharmacol Exp Ther; 2006 Mar; 316(3):1300-9. PubMed ID: 16339391
[TBL] [Abstract][Full Text] [Related]
11. Expression of human aldo-keto reductase 1C2 in cell lines of peritoneal endometriosis: potential implications in metabolism of progesterone and dydrogesterone and inhibition by progestins.
Beranič N; Brožič P; Brus B; Sosič I; Gobec S; Lanišnik Rižner T
J Steroid Biochem Mol Biol; 2012 May; 130(1-2):16-25. PubMed ID: 22245609
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the Potential of Bile Acid Methyl Esters as Inhibitors of Aldo-keto Reductase 1C2: Insight from Molecular Docking, Virtual Screening, Experimental Assays and Molecular Dynamics.
Marinović MA; Petri ET; Grbović LM; Vasiljević BR; Jovanović-Šanta SS; Bekić SS; Ćelić AS
Mol Inform; 2022 Oct; 41(10):e2100256. PubMed ID: 35393780
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid-induced androgen inactivation by aldo-keto reductase 1C2 promotes adipogenesis in human preadipocytes.
Veilleux A; Côté JA; Blouin K; Nadeau M; Pelletier M; Marceau P; Laberge PY; Luu-The V; Tchernof A
Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E941-9. PubMed ID: 22275760
[TBL] [Abstract][Full Text] [Related]
14. Porcine aldo-keto reductase 1C subfamily members AKR1C1 and AKR1C4: Substrate specificity, inhibitor sensitivity and activators.
Endo S; Morikawa Y; Matsunaga T; Hara A; Nishinaka T
J Steroid Biochem Mol Biol; 2022 Jul; 221():106113. PubMed ID: 35398259
[TBL] [Abstract][Full Text] [Related]
15. Sex hormones reduce NNK detoxification through inhibition of short-chain dehydrogenases/reductases and aldo-keto reductases in vitro.
Stapelfeld C; Maser E
Chem Biol Interact; 2017 Oct; 276():167-173. PubMed ID: 28257955
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic analysis of AKR1C2-4 and HSD17B6 genes in subjects 46,XY with hypospadias.
Mares L; Vilchis F; Chávez B; Ramos L
J Pediatr Urol; 2020 Oct; 16(5):689.e1-689.e12. PubMed ID: 32732174
[TBL] [Abstract][Full Text] [Related]
17. Reversal of inflammation-associated dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and drug resistance in nonsmall cell lung cancer cells by wogonin and chrysin.
Wang HW; Lin CP; Chiu JH; Chow KC; Kuo KT; Lin CS; Wang LS
Int J Cancer; 2007 May; 120(9):2019-27. PubMed ID: 17266043
[TBL] [Abstract][Full Text] [Related]
18. Activation of polycyclic aromatic hydrocarbon trans-dihydrodiol proximate carcinogens by human aldo-keto reductase (AKR1C) enzymes and their functional overexpression in human lung carcinoma (A549) cells.
Palackal NT; Lee SH; Harvey RG; Blair IA; Penning TM
J Biol Chem; 2002 Jul; 277(27):24799-808. PubMed ID: 11978787
[TBL] [Abstract][Full Text] [Related]
19. The effect of allelic variation in aldo-keto reductase 1C2 on the in vitro metabolism of dihydrotestosterone.
Takahashi RH; Grigliatti TA; Reid RE; Riggs KW
J Pharmacol Exp Ther; 2009 Jun; 329(3):1032-9. PubMed ID: 19258517
[TBL] [Abstract][Full Text] [Related]
20. Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism.
Ji Q; Chang L; VanDenBerg D; Stanczyk FZ; Stolz A
Prostate; 2003 Mar; 54(4):275-89. PubMed ID: 12539226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
